Stockreport

Palisade Bio Shares Phase 1b PALI-2108 Data Showing Safety, PK and Early Crohn's Efficacy Signals [Yahoo! Finance]

Palisade Bio, Inc.  (PALI) 
PDF no typical PDE4-related side effects, providing a safety foundation to move into longer studies. The study showed encouraging PK/PD and early efficacy signals—plasma t [Read more]